TC LPA5 4
CAY-17719-50 50 mg
Synonyms: TC Lysophosphatidic Acid Receptor 5 4
Data Sheet: 
CAS
1393814-38-4
Formulation
A solid
Purity
≥98%
MW
410,9
Shipment
-20
Long Term Storage
-20
Description
An LPA5 antagonist (IC50 = 0.8 µM in McA-RH7777 cells expressing the human receptor); selectively inhibits the aggregation of washed isolated human platelets induced by 1-palmitoyl LPA over collagen or TRAP (IC50s = 0.8, >10, and >10 µM, respectively); inhibits NSD2 (IC50 = 8.5 µM) and 29 other methyltransferases (IC50s = 0.33-71 µM); reduces tumor volume in a CGTH-W-3 thyroid cancer mouse xenograft model at 10 mg/kg; prevents brain tissue loss and neurological deficits, as well as increases survival, neurogenesis in the subventricular zone, and angiogenesis in the penumbra, in a mouse model of transient MCAO-induced ischemic stroke at 10 mg/kg, i.p.
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
